key: cord-0732595-2u1w5abk
authors: Ross, Lainie Friedman
title: COVID-19 Vaccine Refusal and Organ Transplantation
date: 2022-03-04
journal: Am J Kidney Dis
DOI: 10.1053/j.ajkd.2022.02.009
sha: b1b2260ff4507961fb3b840376808634765cf600
doc_id: 732595
cord_uid: 2u1w5abk

nan

For 2 years, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus responsible for the corona virus disease 2019 (COVID-19) pandemic has wreaked havoc on our health systems. The pandemic has adversely impacted the transplant community--from organ procurement to outcomes. In the United States (US), the development and free distribution of several effective vaccines has not been the panacea that we had hoped for as uptake of COVID-19 vaccines has been mired in controversy. This has led to moral distress among transplant professionals about how to deal with vaccine refusers. Several programs have denied maintaining vaccine refusers on deceased donor organ waitlists. [ Each claim can be refuted. First, whether patients are to blame for being at risk for COVID-19 is morally irrelevant; physicians have a fiduciary responsibility to patients, which implies a duty or obligation to act in patients' best medical interests. The transplant community has set thresholds of graft and patient survival thresholds above which candidates in organ failure are deemed to be able to benefit from organ transplantation and eligible for listing. Vaccine status can be considered "one component of clinical risk" that determines expected graft and patient survival over time. [7] Candidates whose expected outcomes meet the minimum CMS requirement threshold should be waitlisted, even if they fail to maximize their odds for the best clinical outcome. While these candidates are making bad choices and they should be strongly counselled to get vaccinated, penalizing them is inconsistent with our fiduciary obligation of beneficence.

Second, vaccine refusal in and of itself is not proof of non-compliance. Most transplant programs strongly recommend but do not mandate vaccines for other vaccine preventable diseases. [8] While COVID-19 is more lethal than many of those other infections and we are in the midst of a pandemic, new effective treatments are being developed, although much still needs to be learned regarding safety and efficacy.

Third, the claim that transplanting unvaccinated candidates wastes organs and threatens a program's CMS status because of high mortality is problematic because there are ways to mitigate risk regardless of vaccination status (e.g., social distancing, wearing of effective masks, J o u r n a l P r e -p r o o f avoiding indoor crowds).While the risks from SARS-CoV-2 in transplant recipients is serious, the vast majority of unvaccinated transplant recipients infected with SARS-CoV-2 recover. An early meta-analysis of global case series found that "a higher admission rate was noted but overall outcome was similar to the general population," [9] although other meta-analyses have demonstrated both severity and mortality to be higher in transplant patients. [10] Even if unvaccinated candidates are at greater risk of mortality, the threat to a program's status is also true of other non-ideal candidates (e.g., older candidates). Candidates who meet graft-and patient-outcome thresholds adjusted for vaccine status should be offered an organ.

Fourth, the risk the unvaccinated transplant patient poses to other patients and to the transplant community is real, but much lower if the transplant team is vaccinated and we adopt other mitigation strategies in our hospitals. Vaccine refusers amongst organ candidates will be the exception. Before we threaten unvaccinated candidates with de-listing, we must acknowledge that only 73% of health care workers were vaccinated by September 2021, even though we were given first dibs. [11] Many health professionals don't get annual flu shots, exposing our patients unwittingly to risks. Making COVID-19 vaccine refusal an absolute exclusion for waitlisting is too severe.

The main moral problem with a policy to refuse to transplant unvaccinated candidates, then, is an equity concern. Under NOTA [12] and reaffirmed by the Final Rule, [13] the transplant community is charged not only with ensuring "best use of organs" but also the responsibility to balance equity and efficiency. COVID-19 vaccine refusers are not a random group, with higher vaccine hesitancy in communities of African ancestry and Hispanic ethnicity, [14] who are already disadvantaged by many transplant allocation policies and practices. [15, 16] While the racial and ethnic gap of COVID-19 vaccine uptake has largely disappeared, the gap still persists J o u r n a l P r e -p r o o f for booster shots amongst those who are eligible. [17] Given the structural racism that undergirds medical history in the US, [18] and the call to promote racial equity in organ transplantation, [19] we must consider the unintended consequences that a policy to exclude the unimmunized from the waitlist will cause. A mandatory policy may exacerbate racial and ethnic disparities. Rather than penalize, we must take the time to hear the concerns of the unvaccinated and to work with them to overcome misinformation and mistrust.

Even if transplant programs are within their legal right to discriminate against candidates who refuse the COVID-19 vaccine, one must ask how far the community is willing to go. Will transplant teams mandate testing to ensure that the vaccine recipients mounted an effective immune response, or will it mandate multiple boosters? If the patient is a minor, what will the transplant team do if they are not vaccinated (because of age) or because of parental concerns?

One must also wonder what will happen if the transplant candidate's designated caretaker or other family members refuse to be vaccinated. Will the transplant community demand that candidates find another support person and what will we do if the candidate cannot?

The desire to exclude those patients whose primary support person refused vaccination is not hypothetical. The clinical ethics consultation service at Loyola University Health System (Neiswanger Institute for Bioethics) recommended such a policy to its transplant programs. [20] They argued: "it has long been precedent in allocating organs to require recipients to have social support that promotes the possibility of successful living post-transplant." [20] This precedent may be a major source of inequity. In 2019, Ladin and colleagues conducted a survey to determine how many patients are excluded from organ waitlists due to lack of social support.

They noted that "subjective criteria such as social support are especially susceptible to implicit bias, exacerbating concerns about inconsistent use and disparities." [21] They also noted that concerns. [21] I totally support recommending, encouraging, and even nudging transplant candidates and their social support person and other household members to get vaccinated for COVID-19. This is one of those health care settings in which directive counseling is not only morally 

Fact check: Colorado hospital and others are requiring COVID-19 vaccine for transplant patients. USA Today

Hospital Defends Decision to Deny Heart Transplant to Unvaccinated Man

It's Okay for Docs to Refuse to Treat Unvaccinated Patients

Responsibility, alcoholism, and liver transplantation

Psychosocial evaluation of organ transplant candidates. A comparative survey of process, criteria, and outcomes in heart, liver, and kidney transplantation

Kidney transplantation and patients who decline SARS-CoV-2 vaccination: an ethical framework

On Behalf of The AST ID Community of Practice. Vaccination of solid organ transplant candidates and recipients: Guidelines from the American society of transplantation infectious diseases community of practice

COVID-19 in solid organ transplant recipients: A systematic review and meta-analysis of current literature

The association between severe or death COVID-19 and solid organ transplantation: A systematic review and meta-analysis

Health Workers Aren't Immune to Vaccine Misinformation. NPR

Pub L No. 98-507

Centers for Medicare & Medicaid Services 42 CFR Parts 405, 482, 488, and 498 Medicare Program; Hospital Conditions of Participation: Requirements for Approval and Re-Approval of Transplant Centers To Perform Organ Transplants; Final Rule Fed Reg

COVID-19 vaccine hesitancy: Race/ethnicity, trust, and fear

Racial and Ethnic Disparities in Kidney Transplant Access Within a Theoretical Context of Medical Eligibility

The Gross Inequality of Organ Transplants in America. The New Republic

KFF COVID-19 Vaccine Monitor

Putting Ethics and Clinical Decision Making before Politics: Requiring COVID-19 Immunization for Solid Organ Transplantation (SOT) Candidates and their Support Team

Excluding patients from transplant due to social support: Results from a national survey of transplant providers